PlainPill

Vinpocetine

People mainly take Vinpocetine for focus. Based on 33 first-hand reports and 13 meta-analyses & systematic reviews in the medical literature. Ranked #240 of 1,974 overall.

39
User score
Mixed
12% positive0% mixed9% negative79% unclear

Of reports that state an outcome, 57% are positive.

Clinical research
AStrong research base
13
meta-analyses
20
RCTs
712
papers

What Vinpocetine does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.

Cochrane Database Syst Rev · 2003 · Meta-analysis / systematic review
Vinpocetine for cognitive impairment and dementia

Conclusion: Although the basic science is interesting, the evidence for beneficial effect of vinpocetine on patients with dementia is inconclusive and does not support clinical use. The drug seems to have few adverse effects at the doses used in the studies. Large studies evaluating the use of vinpocetine for people suffering from well defined types of cognitive impairment are needed to explore possible efficacy of this treatment.

PubMed 12535455 ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

20 mgas reported
20 mg2x daily
20 mg5 days on, 2 off

Reported side effects

How often each side effect came up across all reports.

brain fog ×1tingling ×1headache ×1

What users say

Verbatim quotes, shortened only — each links to the original discussion.

Other options for focus

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate